Skip to main content
Erschienen in: International Journal of Colorectal Disease 7/2018

23.04.2018 | Original Article

Glasgow prognostic score is a practical predictive index for postoperative intra-abdominal septic complications after bowel resection in Crohn’s disease patients

verfasst von: Yibin Zhu, Haili Xu, Wei Liu, Weilin Qi, Xiaoyan Yang, Lingna Ye, Qian Cao, Wei Zhou

Erschienen in: International Journal of Colorectal Disease | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Postoperative intra-abdominal septic complications (IASCs) are not uncommon in patients with Crohn’s disease (CD). The appropriate index to predict postoperative IASCs in these individuals remains unknown. This study investigates whether the inflammation-based Glasgow prognostic score (GPS) is predictive in the setting of postoperative IASC CD patients who underwent elective bowel resection.

Methods

A consecutive cohort of 163 CD patients who underwent elective intestinal resection from July 2012 to March 2016 was retrospectively analyzed. Patients were divided into two GPS groups, one lower and one higher. The GPS was defined by serum levels of C-reactive protein and albumin. Univariate and multivariate analyses were conducted to identify risk factors for postoperative IASCs.

Results

Postoperative IASCs occurred in 25 (15.3%) patients. Compared with patients in the lower GPS group, patients with a higher GPS had a higher incidence of postoperative IASCs (9.85 vs. 38.71%, P < 0.001) and experienced longer postoperative hospital stay (10.53 ± 7.00 vs. 15.71 ± 9.17, P = 0.001). Univariate and multivariate analyses revealed preoperative GPS [odds ratio (OR) 5.016, 95% confidence interval (CI) 1.134–22.193, P = 0.034] and penetrating behavior (OR 4.495, 95% CI 1.377–14.670, P = 0.013) to be independent risk factors for postoperative IASCs.

Conclusions

A preoperative GPS can serve as a useful index for predicting manifestation of postoperative IASCs after bowel resection in patients with CD. Perioperative optimization is required to improve postoperative outcomes for patients with higher GPS.
Literatur
1.
2.
Zurück zum Zitat Nandivada P, Poylin V, Nagle D (2012) Advances in the surgical management of inflammatory bowel disease. Curr Opin Gastroenterol 28(1):47–51CrossRefPubMed Nandivada P, Poylin V, Nagle D (2012) Advances in the surgical management of inflammatory bowel disease. Curr Opin Gastroenterol 28(1):47–51CrossRefPubMed
3.
Zurück zum Zitat Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP (2005) Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54(2):237–241CrossRefPubMedPubMedCentral Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP (2005) Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 54(2):237–241CrossRefPubMedPubMedCentral
4.
5.
Zurück zum Zitat Landsend E, Johnson E, Johannessen HO, Carlsen E (2006) Long-term outcome after intestinal resection for Crohn’s disease. Scand J Gastroenterol 41(10):1204–1208CrossRefPubMed Landsend E, Johnson E, Johannessen HO, Carlsen E (2006) Long-term outcome after intestinal resection for Crohn’s disease. Scand J Gastroenterol 41(10):1204–1208CrossRefPubMed
6.
Zurück zum Zitat Iesalnieks I, Kilger A, Glass H et al (2008) Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Color Dis 23(12):1167–1174CrossRef Iesalnieks I, Kilger A, Glass H et al (2008) Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome. Int J Color Dis 23(12):1167–1174CrossRef
7.
Zurück zum Zitat Kanazawa A, Yamana T, Okamoto K, Sahara R (2012) Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn’s disease. Dis Colon Rectum 55(9):957–962CrossRefPubMed Kanazawa A, Yamana T, Okamoto K, Sahara R (2012) Risk factors for postoperative intra-abdominal septic complications after bowel resection in patients with Crohn’s disease. Dis Colon Rectum 55(9):957–962CrossRefPubMed
8.
Zurück zum Zitat Morar PS, Hodgkinson JD, Thalayasingam S, Koysombat K, Purcell M, Hart AL, Warusavitarne J, Faiz O (2015) Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn’s disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohns Colitis 9(6):483–491CrossRefPubMed Morar PS, Hodgkinson JD, Thalayasingam S, Koysombat K, Purcell M, Hart AL, Warusavitarne J, Faiz O (2015) Determining predictors for intra-abdominal septic complications following ileocolonic resection for Crohn’s disease-considerations in pre-operative and peri-operative optimisation techniques to improve outcome. J Crohns Colitis 9(6):483–491CrossRefPubMed
9.
Zurück zum Zitat Zuo L, Li Y, Wang H, Zhu W, Zhang W, Gong J, Li N, Li J (2015) A practical predictive index for intra-abdominal septic complications after primary anastomosis for Crohn’s disease: change in C-reactive protein level before surgery. Dis Colon Rectum 58(8):775–781CrossRefPubMed Zuo L, Li Y, Wang H, Zhu W, Zhang W, Gong J, Li N, Li J (2015) A practical predictive index for intra-abdominal septic complications after primary anastomosis for Crohn’s disease: change in C-reactive protein level before surgery. Dis Colon Rectum 58(8):775–781CrossRefPubMed
10.
Zurück zum Zitat Zhang M, Gao X, Chen Y, Zhi M, Chen H, Tang J, Su M, Yao J, Yang Q, Chen J, Hu P, Liu H (2015) Body mass index is a marker of nutrition preparation sufficiency before surgery for Crohn's disease from the perspective of intra-abdominal septic complications: a retrospective cohort study. Medicine (Baltimore) 94(35):e1455CrossRef Zhang M, Gao X, Chen Y, Zhi M, Chen H, Tang J, Su M, Yao J, Yang Q, Chen J, Hu P, Liu H (2015) Body mass index is a marker of nutrition preparation sufficiency before surgery for Crohn's disease from the perspective of intra-abdominal septic complications: a retrospective cohort study. Medicine (Baltimore) 94(35):e1455CrossRef
11.
Zurück zum Zitat Tzivanakis A, Singh JC, Guy RJ, Travis SPL, Mortensen NJ, George BD (2012) Influence of risk factors on the safety of ileocolic anastomosis in Crohn’s disease surgery. Dis Colon Rectum 55(5):558–562CrossRefPubMed Tzivanakis A, Singh JC, Guy RJ, Travis SPL, Mortensen NJ, George BD (2012) Influence of risk factors on the safety of ileocolic anastomosis in Crohn’s disease surgery. Dis Colon Rectum 55(5):558–562CrossRefPubMed
12.
Zurück zum Zitat Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50(3):331–336CrossRefPubMed Alves A, Panis Y, Bouhnik Y, Pocard M, Vicaut E, Valleur P (2007) Risk factors for intra-abdominal septic complications after a first ileocecal resection for Crohn’s disease: a multivariate analysis in 161 consecutive patients. Dis Colon Rectum 50(3):331–336CrossRefPubMed
13.
Zurück zum Zitat Myrelid P, Olaison G, Sjodahl R et al (2009) Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 52(8):1387–1394CrossRefPubMed Myrelid P, Olaison G, Sjodahl R et al (2009) Thiopurine therapy is associated with postoperative intra-abdominal septic complications in abdominal surgery for Crohn's disease. Dis Colon Rectum 52(8):1387–1394CrossRefPubMed
14.
Zurück zum Zitat Yamamoto T, Allan RN, Keighley MR (2000) Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum 43(8):1141–1145CrossRefPubMed Yamamoto T, Allan RN, Keighley MR (2000) Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum 43(8):1141–1145CrossRefPubMed
15.
Zurück zum Zitat Serradori T, Germain A, Scherrer ML, Ayav C, Perez M, Romain B, Palot JP, Rohr S, Peyrin-Biroulet L, Bresler L (2013) The effect of immune therapy on surgical site infection following Crohn’s disease resection. Br J Surg 100(8):1089–1093CrossRefPubMed Serradori T, Germain A, Scherrer ML, Ayav C, Perez M, Romain B, Palot JP, Rohr S, Peyrin-Biroulet L, Bresler L (2013) The effect of immune therapy on surgical site infection following Crohn’s disease resection. Br J Surg 100(8):1089–1093CrossRefPubMed
16.
Zurück zum Zitat Riss S, Bittermann C, Zandl S, Kristo I, Stift A, Papay P, Vogelsang H, Mittlböck M, Herbst F (2010) Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn’s disease: who is at risk? Color Dis 12(10 Online):e298–e303CrossRef Riss S, Bittermann C, Zandl S, Kristo I, Stift A, Papay P, Vogelsang H, Mittlböck M, Herbst F (2010) Short-term complications of wide-lumen stapled anastomosis after ileocolic resection for Crohn’s disease: who is at risk? Color Dis 12(10 Online):e298–e303CrossRef
17.
Zurück zum Zitat Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC (2012) Risk factors for complications after bowel surgery in Korean patients with Crohn's disease. J Korean Surg Soc 83(3):141–148CrossRefPubMedPubMedCentral Yang SS, Yu CS, Yoon YS, Yoon SN, Lim SB, Kim JC (2012) Risk factors for complications after bowel surgery in Korean patients with Crohn's disease. J Korean Surg Soc 83(3):141–148CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Ramsey S, Lamb GW, Aitchison M et al (2007) Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer 109(2):205–212CrossRefPubMed Ramsey S, Lamb GW, Aitchison M et al (2007) Evaluation of an inflammation-based prognostic score in patients with metastatic renal cancer. Cancer 109(2):205–212CrossRefPubMed
19.
Zurück zum Zitat Mcmillan DC, Crozier JE, Canna K et al (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Color Dis 22(8):881–886CrossRef Mcmillan DC, Crozier JE, Canna K et al (2007) Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Color Dis 22(8):881–886CrossRef
20.
Zurück zum Zitat Ishizuka M, Kita J, Shimoda M, Rokkaku K, Kato M, Sawada T, Kubota K (2009) Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol 100(1):38–42CrossRefPubMed Ishizuka M, Kita J, Shimoda M, Rokkaku K, Kato M, Sawada T, Kubota K (2009) Systemic inflammatory response predicts postoperative outcome in patients with liver metastases from colorectal cancer. J Surg Oncol 100(1):38–42CrossRefPubMed
21.
Zurück zum Zitat Glen P, Jamieson NB, Mcmillan DC et al (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6(5):450–453CrossRefPubMed Glen P, Jamieson NB, Mcmillan DC et al (2006) Evaluation of an inflammation-based prognostic score in patients with inoperable pancreatic cancer. Pancreatology 6(5):450–453CrossRefPubMed
22.
Zurück zum Zitat Kondrup J, Allison SP, Elia M, Vellas B, Plauth M, Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN) (2003) ESPEN guidelines for nutrition. Screening 2002. Clin Nutr 22(4):415–421CrossRefPubMed Kondrup J, Allison SP, Elia M, Vellas B, Plauth M, Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN) (2003) ESPEN guidelines for nutrition. Screening 2002. Clin Nutr 22(4):415–421CrossRefPubMed
23.
Zurück zum Zitat Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753CrossRefPubMedPubMedCentral Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55(6):749–753CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV Jr (2008) Prevalence of penetrating disease and extraintestinal manifestations of Crohn’s disease detected with CT enterography. Inflamm Bowel Dis 14(12):1701–1706CrossRefPubMed Bruining DH, Siddiki HA, Fletcher JG, Tremaine WJ, Sandborn WJ, Loftus EV Jr (2008) Prevalence of penetrating disease and extraintestinal manifestations of Crohn’s disease detected with CT enterography. Inflamm Bowel Dis 14(12):1701–1706CrossRefPubMed
25.
Zurück zum Zitat Li G, Ren J, Wang G, Hu D, Gu G, Liu S, Ren H, Wu X, Li J (2014) Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. Eur J Clin Nutr 68(4):441–446CrossRefPubMed Li G, Ren J, Wang G, Hu D, Gu G, Liu S, Ren H, Wu X, Li J (2014) Preoperative exclusive enteral nutrition reduces the postoperative septic complications of fistulizing Crohn’s disease. Eur J Clin Nutr 68(4):441–446CrossRefPubMed
26.
Zurück zum Zitat Heerasing N, Thompson B, Hendy P, Heap GA, Walker G, Bethune R, Mansfield S, Calvert C, Kennedy NA, Ahmad T, Goodhand JR (2017) Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn’s disease. Aliment Pharmacol Ther 45(5):660–669CrossRefPubMed Heerasing N, Thompson B, Hendy P, Heap GA, Walker G, Bethune R, Mansfield S, Calvert C, Kennedy NA, Ahmad T, Goodhand JR (2017) Exclusive enteral nutrition provides an effective bridge to safer interval elective surgery for adults with Crohn’s disease. Aliment Pharmacol Ther 45(5):660–669CrossRefPubMed
27.
Zurück zum Zitat Lee JS, Kim HJ, Cho HM, Lee KM, Kye BH (2016) The importance of the Crohn’s disease activity index in surgery for small bowel Crohn’s disease. J Visc Surg 153(5):339–345CrossRefPubMed Lee JS, Kim HJ, Cho HM, Lee KM, Kye BH (2016) The importance of the Crohn’s disease activity index in surgery for small bowel Crohn’s disease. J Visc Surg 153(5):339–345CrossRefPubMed
28.
Zurück zum Zitat Guo Z, Guo D, Gong J, Zhu W, Zuo L, Sun J, Li N, Li J (2016) Preoperative nutritional therapy reduces the risk of anastomotic leakage in patients with Crohn’s disease requiring resections. Gastroenterol Res Pract 2016:5017856PubMed Guo Z, Guo D, Gong J, Zhu W, Zuo L, Sun J, Li N, Li J (2016) Preoperative nutritional therapy reduces the risk of anastomotic leakage in patients with Crohn’s disease requiring resections. Gastroenterol Res Pract 2016:5017856PubMed
29.
Zurück zum Zitat Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246(6):1047–1051CrossRefPubMed Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K (2007) Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg 246(6):1047–1051CrossRefPubMed
30.
Zurück zum Zitat Moyes LH, Leitch EF, Mckee RF et al (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100(8):1236–1239CrossRefPubMedPubMedCentral Moyes LH, Leitch EF, Mckee RF et al (2009) Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 100(8):1236–1239CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Kostner AH, Kersten C, Lowenmark T et al (2016) The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker. J Surg Oncol 114(7):895–899CrossRefPubMed Kostner AH, Kersten C, Lowenmark T et al (2016) The prognostic role of systemic inflammation in patients undergoing resection of colorectal liver metastases: C-reactive protein (CRP) is a strong negative prognostic biomarker. J Surg Oncol 114(7):895–899CrossRefPubMed
32.
Zurück zum Zitat Sugimoto K, Komiyama H, Kojima Y, Goto M, Tomiki Y, Sakamoto K (2012) Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer. Dig Surg 29(6):503–509CrossRefPubMed Sugimoto K, Komiyama H, Kojima Y, Goto M, Tomiki Y, Sakamoto K (2012) Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer. Dig Surg 29(6):503–509CrossRefPubMed
33.
Zurück zum Zitat Solem CA, Loftus EJ, Tremaine WJ et al (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11(8):707–712CrossRefPubMed Solem CA, Loftus EJ, Tremaine WJ et al (2005) Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis 11(8):707–712CrossRefPubMed
34.
Zurück zum Zitat Koelewijn CL, Schwartz MP, Samsom M, Oldenburg B (2008) C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease. World J Gastroenterol 14(1):85–89CrossRefPubMedPubMedCentral Koelewijn CL, Schwartz MP, Samsom M, Oldenburg B (2008) C-reactive protein levels during a relapse of Crohn’s disease are associated with the clinical course of the disease. World J Gastroenterol 14(1):85–89CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Simillis C, Yamamoto T, Reese GE, Umegae S, Matsumoto K, Darzi AW, Tekkis PP (2008) A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol 103(1):196–205CrossRefPubMed Simillis C, Yamamoto T, Reese GE, Umegae S, Matsumoto K, Darzi AW, Tekkis PP (2008) A meta-analysis comparing incidence of recurrence and indication for reoperation after surgery for perforating versus nonperforating Crohn’s disease. Am J Gastroenterol 103(1):196–205CrossRefPubMed
36.
Zurück zum Zitat Bellolio F, Cohen Z, Macrae HM et al (2013) Outcomes following surgery for perforating Crohn’s disease. Br J Surg 100(10):1344–1348CrossRefPubMed Bellolio F, Cohen Z, Macrae HM et al (2013) Outcomes following surgery for perforating Crohn’s disease. Br J Surg 100(10):1344–1348CrossRefPubMed
37.
Zurück zum Zitat Nasir BS, Dozois EJ, Cima RR, Pemberton JH, Wolff BG, Sandborn WJ, Loftus EV, Larson DW (2010) Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease. J Gastrointest Surg 14(12):1859–1865 1865-1866CrossRefPubMed Nasir BS, Dozois EJ, Cima RR, Pemberton JH, Wolff BG, Sandborn WJ, Loftus EV, Larson DW (2010) Perioperative anti-tumor necrosis factor therapy does not increase the rate of early postoperative complications in Crohn's disease. J Gastrointest Surg 14(12):1859–1865 1865-1866CrossRefPubMed
38.
Zurück zum Zitat Esaki M, Matsumoto T, Nakamura S, Yada S, Fujisawa K, Jo Y, Iida M (2006) Factors affecting recurrence in patients with Crohn’s disease under nutritional therapy. Dis Colon Rectum 49(10 Suppl):S68–S74CrossRefPubMed Esaki M, Matsumoto T, Nakamura S, Yada S, Fujisawa K, Jo Y, Iida M (2006) Factors affecting recurrence in patients with Crohn’s disease under nutritional therapy. Dis Colon Rectum 49(10 Suppl):S68–S74CrossRefPubMed
39.
Zurück zum Zitat Swoger JM, Regueiro M (2010) Preventive therapy in postoperative Crohn’s disease. Curr Opin Gastroenterol 26(4):337–343CrossRefPubMed Swoger JM, Regueiro M (2010) Preventive therapy in postoperative Crohn’s disease. Curr Opin Gastroenterol 26(4):337–343CrossRefPubMed
40.
Zurück zum Zitat Nguyen GC, Elnahas A, Jackson TD (2014) The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. J Crohns Colitis 8(12):1661–1667CrossRefPubMed Nguyen GC, Elnahas A, Jackson TD (2014) The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease. J Crohns Colitis 8(12):1661–1667CrossRefPubMed
41.
Zurück zum Zitat Colombel JF, Loftus EJ, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99(5):878–883CrossRefPubMed Colombel JF, Loftus EJ, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99(5):878–883CrossRefPubMed
42.
Zurück zum Zitat Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L (2008) Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 12(10):1730–1736, 1736-1737CrossRefPubMed Kunitake H, Hodin R, Shellito PC, Sands BE, Korzenik J, Bordeianou L (2008) Perioperative treatment with infliximab in patients with Crohn’s disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 12(10):1730–1736, 1736-1737CrossRefPubMed
43.
Zurück zum Zitat Kasparek MS, Bruckmeier A, Beigel F, Müller MH, Brand S, Mansmann U, Jauch KW, Ochsenkühn T, Kreis ME (2012) Infliximab does not affect postoperative complication rates in Crohn’s patients undergoing abdominal surgery. Inflamm Bowel Dis 18(7):1207–1213CrossRefPubMed Kasparek MS, Bruckmeier A, Beigel F, Müller MH, Brand S, Mansmann U, Jauch KW, Ochsenkühn T, Kreis ME (2012) Infliximab does not affect postoperative complication rates in Crohn’s patients undergoing abdominal surgery. Inflamm Bowel Dis 18(7):1207–1213CrossRefPubMed
44.
Zurück zum Zitat Norgard BM, Nielsen J, Qvist N et al (2013) Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study. Aliment Pharmacol Ther 37(2):214–224CrossRefPubMed Norgard BM, Nielsen J, Qvist N et al (2013) Pre-operative use of anti-TNF-alpha agents and the risk of post-operative complications in patients with Crohn's disease--a nationwide cohort study. Aliment Pharmacol Ther 37(2):214–224CrossRefPubMed
45.
Zurück zum Zitat Syed A, Cross RK, Flasar MH (2013) Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn’s disease patients. Am J Gastroenterol 108(4):583–593CrossRefPubMed Syed A, Cross RK, Flasar MH (2013) Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn’s disease patients. Am J Gastroenterol 108(4):583–593CrossRefPubMed
46.
Zurück zum Zitat Kopylov U, Ben-Horin S, Zmora O, Eliakim R, Katz LH (2012) Anti-tumor necrosis factor and postoperative complications in Crohn’s disease: systematic review and meta-analysis. Inflamm Bowel Dis 18(12):2404–2413CrossRefPubMed Kopylov U, Ben-Horin S, Zmora O, Eliakim R, Katz LH (2012) Anti-tumor necrosis factor and postoperative complications in Crohn’s disease: systematic review and meta-analysis. Inflamm Bowel Dis 18(12):2404–2413CrossRefPubMed
Metadaten
Titel
Glasgow prognostic score is a practical predictive index for postoperative intra-abdominal septic complications after bowel resection in Crohn’s disease patients
verfasst von
Yibin Zhu
Haili Xu
Wei Liu
Weilin Qi
Xiaoyan Yang
Lingna Ye
Qian Cao
Wei Zhou
Publikationsdatum
23.04.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Colorectal Disease / Ausgabe 7/2018
Print ISSN: 0179-1958
Elektronische ISSN: 1432-1262
DOI
https://doi.org/10.1007/s00384-018-3035-5

Weitere Artikel der Ausgabe 7/2018

International Journal of Colorectal Disease 7/2018 Zur Ausgabe

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 Ablationstherapie Nachrichten

Nach der Katheterablation von Vorhofflimmern kommt es bei etwa einem Drittel der Patienten zu Rezidiven, meist binnen eines Jahres. Wie sich spätere Rückfälle auf die Erfolgschancen einer erneuten Ablation auswirken, haben Schweizer Kardiologen erforscht.

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 Appendizitis Nachrichten

Schmerzen im Unterbauch, aber sonst nicht viel, was auf eine Appendizitis hindeutete: Ein junger Mann hatte Glück, dass trotzdem eine Laparoskopie mit Appendektomie durchgeführt und der Wurmfortsatz histologisch untersucht wurde.

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

23.04.2024 Operationsvorbereitung Nachrichten

Derzeit wird empfohlen, eine Therapie mit GLP-1-Rezeptoragonisten präoperativ zu unterbrechen. Eine neue Studie nährt jedoch Zweifel an der Notwendigkeit der Maßnahme.

Ureterstriktur: Innovative OP-Technik bewährt sich

19.04.2024 EAU 2024 Kongressbericht

Die Ureterstriktur ist eine relativ seltene Komplikation, trotzdem bedarf sie einer differenzierten Versorgung. In komplexen Fällen wird dies durch die roboterassistierte OP-Technik gewährleistet. Erste Resultate ermutigen.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.